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In a recent study (1), the authors recorded the Galvanic Skin Response
(GSR) preceding and following the intramuscular administration of atropine
and placebo in ten subj ects. The results showed a significant increase in re-
sistance level following atropine as contrasted with the control, thereby indicat-
ing the possibility of applying this technic to the study of certain drugs. However,
further control studies were indicated because the placebo control preceded the
trial in which atropine was administered.
Two additional experiments have been performed to evaluate the effect of
order of administration of drugs on the GSR. The first series was designed to
consider the influence of order of administration on the previously reported drug
effects. This was done by injecting atropine, pilocarpine and placebo in a varied
order in 24 subjects. The second series tested the effect of repeat placebos in 10
subjects. The results of both experiments are included in this report.
MATERIALS AND METHODS
There were 24 white male subjects in the first experimental series. In each
individual the GSR was recorded on three separate occasions preceding and
following the injection of atropine sulfate (gr. 5 o), pilocarpine hydrochloride(gr. i6) or physiological saline (1 cc). The atropine and pilocarpine dosages
were dissolved in 1 cc of physiological saline. All injections were administered
intramuscularly into the extensor surface of the upper arm. The subjects were
normal college males ranging in age from 20—39. All tests were performed in the
morning between the hours of 8 and 12 A.M. in the same room. The time be-
tween pairs of tests varied from 2 to 34 days. In 22 subjects the three tests were
completed in 21 days while the other two required 38 and 39 days.
All possible arrangements of the two drugs and placebo were administered in
the first experimental series as shown in Table I. This consisted of six sequences
of administration each of which included four different subjects. Individuals
were assigned to each sequence in a varied order. This design resulted in the two
independent Patterns (A and B) illustrated in Table I and served the following
purposes:
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TABLE I
Patterns of drug and placebo administration
Experimental Order
Pattern A, Drug Sequence Pattern B , Drug Sequence
1 2 3 4 5 6
First
Second
Third
X P A
A X P
P A X
X A P
P X A
A P X
A—Atropine; P—Pilocarpine; X—Placebo.
1. The subject effects were minimized by having each individual serve as his
own control.
2. The effects arising from particular combinations of drugs and order were
counterbalanced.
3. The effects of introducing different sequences of drug administration
could be partially evaluated by performing separate statistical analyses for
Patterns A and B. This provided independent experimental tests on separate
subject populations and furnished additional evidence for generalizing the ob-
tained results.
There were 10 white male subjects in the second experimental series each of
whom was tested on three different occasions with a placebo consisting of 1 cc
of physiological saline. All injections were administered intramuscularly into
the extensor surface of the upper arm. As in the first experiment, these subjects
were normal college males and ranged in age from 24—35 years. All tests were
made in the morning in the same room. The time between pairs of tests varied
from 1 to 67 days. In eight subjects the three tests were completed in 10 days.
In each test performed in both experimental groups, continuous measurement
of skin resistance was made using a modified Wheatstone bridge which was con-
nected to a D.C. amplifier and direct writing oscillograph (1). Zinc-zinc sulfate
electrodes were attached to the hypothenar eminence of the palm of each hand
and the recording started (1). Following a short period, the test substance was
injected and the GSR was continuously recorded for 45 minutes. This time
interval consisted of 12 sections of record each being 3/ minutes long. Cali-
brations were made prior to, at the middle and end of each experiment in order
to check the stability of the equipment. This also permitted individual readings
to be made from the closest of the three calibrations.
RESULTS
Table II shows the statistical analysis of the results obtained in the first ex-
periment which considered the question of order of drug administration. The
findings are presented separately for Patterns A and B.
The data used for the analysis were obtained from the eleventh section of
record (41 minutes following the injection). This period was selected because
sufficient time had elapsed following the injection to permit the drug effects to be
manifested (1, 2). Resistance readings were made from the last calibration on
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TABLE II
Analysis of variance for pilocarpine-atro pine-placebo series
Sums of Degrees of F RSquares (55)1 Freedom (DF)I - a 10
Source of Variation' _________________ ________________________________ Confidence Leve1[
Pattern Pattern Pattern Pattern Pattern Pattern
A B A B A B
I) Between subjects
(total) 201.61 223.34 11 11
2) Between subjects
drug by order inter-
action 42.50 36.16 2 2 1.20 0.87 P12.5120% = 1.98
3) Between subjects
'error' 159.10 187.18 9 9
4) Within subjects
(total) 328.04 170.82 24 24
5) Drug effects 85.01 88.38 2 2 3.76 9.82 P(s,ls).2% = 8.73
5% = 3.55
6) Order effects 7.36 0.57 2 2 0.33 0.06 P.1a120% = 1.76
7) Within subjects
drug by order inter-
action 31.92 0.81 2 2 1.41 0.09 P12,520% = 1.76
8) Within subjects
'error' 203.74 81.06 18 18
9) Total 529.64 394.16 35 35
* Row I is the sum of rows 2 and S for the 'Sums of Squares' and the 'Degrees of Free-
dom'. Row 4 is the sum of rows 5, 6, 7, and 8 for the 'Sums of Squares' and 'Degrees of
Freedom'. Row S is the sum of rows I and 4 for the 'Sums of Squares' and the 'Degrees
of Freedom'.
Row S indicates the 'between subjects' effects of the drugs which depend on their order
of administration.
Ro\v 7 indicates the 'within subjects' effects of the drugs which depend on their order
of administration.
t The 'Sums of Squares' divided by the corresponding degrees of freedom indicates the
amount of the total variance contributed by each of the factors named in the rows.
t The 'Degrees of Freedom' is the number of observations minus the number of alge-
braically independent linear restrictions placed on them.
5S1/DF1
§ The F-ratio = _____________
SS,reor/DFerror
¶ The 'Confidence Level' is expressed as the percent probability Put5,d12) that an
F-ratio of the size indicated or larger would be expected to occur by chance.
each record in each experimental session. The high nnd low resistnnee readings
were converted into micromhos using the formula /1/R. 1O: (1, 2) and then
averaged. These data were then processed using an analysis of variance design
described by Lindquist (3).
His design provides a means of evaluating the statistical significance of some
of the variables which are included along with the main effects of drug and
order. This is done by means of counterbalancing as shown in Table I, and
provides a more appropriate error term against which to evaluate the statistical
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significance of the main effects. One shortcoming of the design is the failure to
provide an estimate of the variance of possible subject by drug interaction which
is independent of order of administration. A subject by drug interaction would
occur if different subjects showed different magnitudes of reactivity to the
different injections. This can lead to an inflated error term and thereby lower
the obtained significance. The sequence effects of the two Patterns are included
with other differences between the groups. This prevents an independent evalua-
tion of the statistical significance of any variability introduced by sequence
differences.
TABLE III
't' ratios and confidence levels for differences between pairs of drugs
t Ratios
dence LevelsfPattern A Pattern B ConS
Pilocarpinel Atropine Pilocarpine Atropine
Atropine 3.51 3.83 P(df 20) 1% = 2.85
Placebo 2.93 0.58 1.64 2.19 2% = 2.53
5% = 2.09
10% = 1.73
20% = 1.33
* .
___t-ratio
SE12
The 'Confidence Level' is expressed as the percent probability P(df) that a t-ratio of
the size indicated or larger would be expected to occur by chance.
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6.5 EFFECTS OFATROPINE,PILOCARPINE 8 PLACEBO FOR
24 SUBJECTS
PILOCARPINE (P)
PLACEBO IX)
ATNOPINE (A)
START1 2 3 4 5 6 7 8 9 10 II 12
TIME PERIODS-3 3/4 MINUTES/PERIOD
Fia. 1
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Table III shows the significance of the differences obtained between each
pair of drugs and placebo for Patterns A and B. The "t" ratios were obtained
by subtracting the mean of the results for each Pattern for one drug from the
mean of the results of the same Pattern for another test substance. This value
was divided by the standard error of the difference.
Figure 1 graphically illustrates the results obtained with the three test sub-
stances in the entire first series without separating the data into Patterns A and
B. Each point on the graph represents the average -/micromhos in a 3/ min-
ute section of record for all of the 24 subjects. This was done for each of the three
test substances.
Table IV shows the analysis of the results obtained in the 10 subj ects tested
with repeat placebos. The data in this series were also obtained from the eleventh
section of each record (41 minutes after injection). The calculations were made
in the same manner as in the first experimental series.
TABLE IV
Analysis of variance for placebo-placebo-placebo series*
Source of Variation F-Ratio Confidence Levels
1) Order effects
2) Subject effects
3) Order by subject interaction
4) Total
0.86
24.51
8.15
33.52
2
9
18
29
0.95
6.01
P(s.ls)20% = 1.76
Ps,58) 1% = 6.01
* See Table II for explanation of the entries in this table.
toIx
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1
6.5 EFFECTS OF REPEAT PLACEBO FOR to SUB.JEGTS
PLACEBO I
PLACEBO 3
PLACEBO 2
START1 2 3 4 5 6 7 8 9 10 II 2
TIME PERIODS-3 3/4 MINUTES/PERIOD
Fio. 2
184 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Figure 2 shows the results of the three placebo tests in the second
mental series. Each point on the graph represents the average -/micromhos
for a 3 minute section of record for all of the 10 subjects. This was done for
each of the three placebo runs.
DISCUSSION
The general form of results of the drug-placebo series is illustrated in Table
II for Patterns A and B. The effect of the drugs is significant for Pattern A at
the 5% level and at the 0.2 % level for Pattern B. The effect of order is not sig-
nificant at the 20 % level for either Pattern. The variance* which is attributed to
error for Pattern A is 11.3 and for Pattern B is 4.5. These values may include
some of the effects of order and might, therefore, be somewhat larger than the
true value. However, a variance due to order of 3.7 was found in Pattern A and
0.3 in Pattern B. This makes it unlikely that the effect of order would become
significant if evaluated against a smaller error.
More important than the possible statistical significance of order in the
design, is the relative magnitude of effects attributable to order as compared to
the drugs. The variance due to the drug effects for Pattern A is 42.5 and for
Pattern B 44.4. The variance attributable to the order effects for Pattern A is
3.7 and 0.3 for Pattern B. These data indicate that the effects of order are
considerably less than the drug effects. Therefore, it is possible to conclude that
the significance obtained for the drugs is not materially affected by variations
introduced by order.
The first experiment was primarily intended to evaluate the effect of drug
order; however, it was also possible to analyze individual drug effects. Table
III shows the differences between the means of individual drugs and placebo.
The difference between atropine and pilocarpine is significant at the 1 % level
for Patterns A and B. The difference between atropine and placebo is significant
at the 5% level for Pattern B and not significant at the 20 % level for Pattern A.
The difference between pilocarpine and placebo is significant at the 1 % level
for Pattern A and not significant at the 10% level for Pattern B. These results
are in the theoretically expected direction although some of the above findings
were not statistically significant. However, in other experiments (4), larger
dosages of atropine (gr. ioo) and pilocarpine (gr. j%2) have been found to
produce greater and more significant effects.
Figure 1 graphically shows the combined results obtained in the first experi-
mental series. For the first 7z minutes of record the placebo, pilocarpine and
atropine curves follow a similar pattern. The pilocarpine level shows very little
change in the rest of the experiment. The placebo and atropine curves are
similar for the first 22 minutes. From this point, the placebo and atropine curves
separate with the atropine curve showing the more rapid drop. Patterns similar
to these have been found in other experiments (1, 2, 5).
The analysis of the results in the second experimental series (Table IV) is
* The variance is equal to the 'sums of squares' divided by the corresponding 'degrees
of freedom' (Table II).
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simpler because no drug effects were involved. The effects of order are not sig-
nificant at the 20 % level. The subject effects are significant at the 1 % level and
account for the maj or part of the obtained variance. Figure 2 graphically shows
the similarity between the placebo curves for each of the three tests. This indi-
cates that adaptation does not occur for the conditions under which these ex-
periments were performed. Therefore there is not enough variation between
repeat placebo tests in the same individuals to account for the differences found
between placebo and drugs in other experiments.
CONCLUSIONS
1. In 24 subjects the GSR levels were recorded following injections of atro-
pine, pilocarpine and placebo in a varied order. The results indicate that the
observed drug effects are independent of order of administration.
2. Ten subjects were similarly tested following three placebo injections. The
data shows that significant adaptation did not occur between tests.
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